The CDMO sector is experiencing significant development, fueled by rising specialty pharmaceutical demand and a transition towards contracting of manufacturing processes. Key developments include a greater focus on advanced therapies such as genetic therapies, patient-specific treatments, and complex injectables. This presents possibilities for … Read More